Latest filing published 19 Nov 2024 for Recursion Pharmaceuticals, INC., €25k.
Filing timeline
BuySaleInsider track record
David J. Mauro: trading record in brief
This profile gathers the share dealings of David J. Mauro across 3 companies, led by Prelude Therapeutics Inc, Advaxis, Inc. and Recursion Pharmaceuticals, Inc. The record holds 84 filings, for trades running from 20 October 2014 to 15 November 2024.
The open-market record consists of 31 sales worth €4.9M, with no purchase. Other entries cover 43 share grants and 10 option exercises.
On 19 November 2024 came the latest disclosure, a share grant for €25k in Recursion Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David J. Mauro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,187 shares@ US$6.17520.7% of flowClass A Common StockSEC:0001601830-24-000215:0
- 14,146 shares@ US$6.6972.6% of flowClass A Common StockSEC:0001601830-24-000127:0
- 867 shares@ US$10.016.7% of flowClass A Common StockSEC:0001601830-24-000058:0
- 49,768 shares0Class A Common StockSEC:0001209191-24-003241:1
- 1,892 shares@ US$10.0913.0% of flowClass A Common StockSEC:0001209191-24-003241:2
- 6,040 shares0Class A Common StockSEC:0001209191-24-003241:0
- 190,713 shares0Class A Common StockSEC:0001209191-23-035239:0
- 5,908 shares@ US$30.263.1% of flowCommon StockSEC:0001209191-21-059850:1
- 7,803 shares@ US$31.304.2% of flowCommon StockSEC:0001209191-21-059850:2
- 1,289 shares@ US$32.060.7% of flowCommon StockSEC:0001209191-21-059850:3
- 15,000 shares@ US$1.8917.1% of flowCommon StockSEC:0001209191-21-059850:0
- 7,487 shares@ US$35.914.6% of flowCommon StockSEC:0001209191-21-055307:1
- 2,873 shares@ US$36.921.8% of flowCommon StockSEC:0001209191-21-055307:2
- 4,640 shares@ US$37.793.0% of flowCommon StockSEC:0001209191-21-055307:3
- 15,000 shares@ US$1.8916.7% of flowCommon StockSEC:0001209191-21-055307:0
- 6,116 shares@ US$29.933.1% of flowCommon StockSEC:0001209191-21-050404:1
- 2,063 shares@ US$31.031.1% of flowCommon StockSEC:0001209191-21-050404:2
- 6,721 shares@ US$32.153.7% of flowCommon StockSEC:0001209191-21-050404:3
- 100 shares@ US$32.630.1% of flowCommon StockSEC:0001209191-21-050404:4
- 15,000 shares@ US$1.8916.7% of flowCommon StockSEC:0001209191-21-050404:0
- 4,255 shares@ US$28.132.0% of flowCommon StockSEC:0001209191-21-046013:2
- 300 shares@ US$28.840.1% of flowCommon StockSEC:0001209191-21-046013:3
- 10,445 shares@ US$27.174.8% of flowCommon StockSEC:0001209191-21-046013:1
- 15,000 shares@ US$1.8916.7% of flowCommon StockSEC:0001209191-21-046013:0
- 1,400 shares@ US$30.350.7% of flowCommon StockSEC:0001209191-21-039261:1
25 of 84 declarations
